SMi Group is proud to announce the return of Europe’s only Parallel Trade conference. Back for the 12th year, Parallel Trade returns to London on 6th-7th February 2018.
Over the years, the European Single market has allowed for pharmaceuticals to be imported and exported freely between member states without the permission of the manufacturers. However, with the arrival of Brexit and guidelines to immanently enforce the Falsified Medicines Directive (FMD) by 2019, the market for pharmaceutical parallel trade is changing.
Join us as we discuss the latest changes to regulation, their implementation and major court cases in intellectual property influencing distribution practices. We will also be exploring the safety of patients in relation to the surge in pharmaceutical E-commerce and ways in which currency fluctuations are likely to disrupt the flow of drugs to certain countries in the EU and beyond.
With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Parallel Trade event. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers
Parallel Trade 2018 will cover the important issues of:
– Maintaining the integrity of the supply chain
– Addressing recent developments concerning intellectual property and regulatory law
– Forecasting currency fluctuations across the single market and the affect this might have on drug shortages, prices and patient accessibility
– Exploring how Brexit will impact pharmaceutical trade and
– market access in Europe
– Providing an insight into current anti-trust investigations from industry leaders and the consequences this could have on pharmaceutical parallel trade